quinidine has been researched along with Brugada Syndrome in 95 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (36.84) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (15.79) | 29.6817 |
| 2010's | 40 (42.11) | 24.3611 |
| 2020's | 5 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, M; Kawai, H; Kokawa, T; Shimane, A; Takaya, T; Yamamoto, H | 1 |
| Akin, I; Albers, S; Cyganek, L; Diecke, S; Dinkel, H; Duru, F; El-Battrawy, I; Hohn, A; Huang, M; Janssen, JWG; Kleinsorge, M; Lan, H; Lang, S; Li, X; Li, Y; Liao, Z; Maywald, L; Müller, J; Qiao, L; Rose, L; Saguner, A; Schimanski, T; Swamy, N; Xi, Y; Xu, Q; Yang, Z; Zhang, F; Zhao, Z; Zhong, R; Zhou, X | 1 |
| Aguilar, M; Cadrin-Tourigny, J; Compagno, P; Daval, C; Dyrda, K; Ortmans, S; Rivard, L; Tadros, R | 1 |
| Chen, HB; Ding, SY; Liu, YH; Pan, XH; Qian, NJ; Wang, YP; Wei, QC; Wu, L; Ye, SF | 1 |
| Fonseca-Alaniz, MH; Joviano-Santos, JV; Krieger, JE; Neri, EA; Pereira, AC; Roman-Campos, D; Santos-Miranda, A | 1 |
| Belhassen, B; Biton, Y; Mowaswes, M | 1 |
| Anguera, I; Brugada, J; Cequier, Á; Dallaglio, PD; García-Alberola, A; Sabaté, X | 1 |
| Andorin, A; Babuty, D; Davy, JM; Defaye, P; Deharo, JC; Delasalle, B; Esnault, S; Fouchard, S; Gourraud, JB; Hermida, JS; Klug, D; le Marec, H; Leenhardt, A; Mabo, P; Mansourati, J; Maury, P; Probst, V; Sacher, F; Sadoul, N | 1 |
| Belhassen, B | 3 |
| Bajcetic, M; Bozic, B; Kezic, A; Uzelac, TV | 1 |
| Agudo-Mena, JL; Álvarez-Chinchilla, PJ; Encabo-Durán, B; Romero-Pérez, D; Silvestre-Salvador, JF | 1 |
| Viskin, S | 2 |
| Belhassen, B; Blich, M; Chetboun, I; Fogelman, R; Geist, M; Glick, A; Glikson, M; Ilan, M; Konstantino, Y; Laish-Farkash, A; Leshem, E; Mazo, A; Michowitz, Y; Rahkovich, M; Rosso, R; Strasberg, B; Suleiman, M; Swissa, M | 1 |
| Alak, A; Andorin, A; Angaran, P; Atallah, J; Ayala-Paredes, F; Cheung, CC; Deif, B; Dorian, P; Green, MS; Gula, LJ; Healey, JS; Konieczny, KM; Krahn, AD; Lashevsky, I; Malhi, N; Pang, B; Roberts, JD; Simpson, CS; Steinberg, C; Sultan, O; Tadros, R | 1 |
| Aiba, T; Allocca, G; Andorin, A; Arbelo, E; Behr, ER; Belhassen, B; Brugada, J; Brugada, P; Brugada, R; Calo, L; Casado-Arroyo, R; Champagne, J; Conte, G; Corrado, D; Delise, P; Denjoy, I; Gaita, F; Giustetto, C; Gonzalez Corcia, MC; Gourraud, JB; Hirao, K; Hochstadt, A; Huang, Z; Jespersen, CH; Juang, JJM; Kamakura, T; Kim, SH; Kusano, KF; Leenhardt, A; Leshem, E; Mabo, P; Maeda, S; Mazzanti, A; Michowitz, Y; Milman, A; Mizusawa, Y; Nam, GB; Postema, PG; Priori, SG; Probst, V; Sacher, F; Sarquella-Brugada, G; Takagi, M; Takahashi, Y; Tfelt-Hansen, J; Veltmann, C; Wijeyeratne, YD; Wilde, AAM; Yan, GX | 1 |
| Bastian, D; Furlanello, F; Rittger, H; Vitali Serdoz, L | 1 |
| Antzelevitch, C; Barajas-Martínez, H; Betzenhauser, M; Di Diego, JM; Hu, D; Minoura, Y; Nesterenko, VV; Panama, BK | 1 |
| Adler, A; Asrar, F; Belhassen, B; Boyle, NG; Daoulah, A; Guevara-Valdivia, ME; Halkin, A; Krahn, AD; Rosso, R; Schapachnik, E; Shivkumar, K; Viskin, S; Wilde, AA; Zipes, DP | 1 |
| Brunetti, ND; Di Biase, M; Pellegrino, PL | 1 |
| Bouzeman, A; Denjoy, I; Extramiana, F; Hermida, JS; Leenhardt, A; Marijon, E; Messali, A; Narayanan, K; Traulle, S | 1 |
| Boulé, S; Brigadeau, F; Kouakam, C | 1 |
| Bouzeman, A; Leenhardt, A | 1 |
| Márquez, MF; Tonet, J | 1 |
| Barbonaglia, L; Bianchi, F; Castagno, D; Cerrato, N; Ferraro, A; Giachino, D; Giustetto, C; Gribaudo, E; Richiardi, E; Scrocco, C | 1 |
| Aizawa, Y; Ashihara, T; Hasegawa, K; Horie, M; Itoh, H; Jo, H; Kimura, H; Yamamoto, T | 1 |
| Einbinder, T; Fogelman, R; Lowenthal, A | 1 |
| Baranchuk, A; Jastrzębski, M; Kukla, P; Pérez-Riera, AR; Szafran, B | 1 |
| Anguera, I; Brugada, J; Cequier, A; Dallaglio, P; García-Alberola, A; Martínez, JG; Peinado, R; Pérez, L; Rubín, JM; Toquero, J | 1 |
| Chen, C; Geng, J; Shan, Q; Shen, T; Yuan, B; Zhou, X | 1 |
| Brugada, P; Dendramis, G; Sieira, J | 1 |
| Brugada, P; Sieira, J | 1 |
| Shalev, A; Zeller, L | 1 |
| Antzelevitch, C; Belhassen, B; Shimizu, W; Tan, HL; Viskin, S; Wilde, AA | 1 |
| Kowey, P; Link, M | 1 |
| Belhassen, B; Glick, A; Viskin, S | 1 |
| Bahlmann, E; Kuck, KH; Kyriazis, K; van der Schalk, H | 1 |
| Baruteau, AE; Mabo, P; Probst, V | 1 |
| Kodama, S; Maruyama, S; Miyoshi, K; Shiga, Y; Sumi, S; Tojou, H; Urata, H; Yamanouchi, Y | 1 |
| Divakaran, VG; Lakkis, NM; Shiue, HC | 1 |
| Becker, R; Katus, HA; Schweizer, PA; Thomas, D | 1 |
| Belhassen, B; Viskin, S; Wilde, AA | 1 |
| Olsson, G | 1 |
| Estes, NA; Page, RL | 1 |
| Martinek, M; Purerfellner, H | 1 |
| Dautova, Y; Grace, AA; Huang, CL; Zhang, Y | 1 |
| Ashino, S; Hirayama, A; Kasamaki, Y; Kofune, M; Kunimoto, S; Mano, H; Nagashima, K; Nakai, T; Ohkubo, K; Okumura, Y; Watanabe, I | 1 |
| Grace, AA; Huang, CL; Martin, CA | 1 |
| Furniss, G | 1 |
| Bonny, A; Cárdenas, M; De Sisti, A; Gómez-Flores, J; Hernández-Castillo, E; Hidden-Lucet, F; Iturralde, P; Márquez, MF; Nava, S; Tonet, J | 1 |
| LENDLE, L; WENDHUT, G | 1 |
| KLAYMAN, MI; LINENTHAL, AJ; WINER, BM | 1 |
| BOONE, JA; JENKINS, LB; NIGELS, FE | 1 |
| ARORA, RB; MADAN, BR; SHARMA, VN | 1 |
| BAKER, CG; ROBINSON, BH; TROUNCE, JR | 1 |
| AGNOLETTO, A | 1 |
| GERSTNER, K | 1 |
| EICHLER, O; SECKFORT, H; VOIT, K | 1 |
| CONSTANTINEANU, M; ILIESCU, CC; PANTZER, M | 1 |
| BERMAN, R | 1 |
| PACHECO, JM | 1 |
| SCHOTT, A | 1 |
| LENARD, G; SZEKERES, L | 1 |
| ABREU, DC; ARAUJO, LR; da SILVEIRA, I; GOMES, M | 1 |
| GIMENO, AL; GIMENO, M; WEBB, JL | 1 |
| HUANG, TF | 1 |
| ROKSETH, R | 1 |
| SZEKERES, L; WILLIAMS, EM | 1 |
| KEMPEN, RR; VAN HORN, G | 1 |
| FAY, JE; KELLY, HG; LAVERTY, SG | 1 |
| HOUK, P | 1 |
| DELAFUENTE, L; HORSLEY, HT | 1 |
| SELZER, A; WRAY, HW | 1 |
| ADAMS, CW | 1 |
| AUG, MC; CHERRIER, F; PETITIER, H; REBEIX, G; RENAUD, J | 1 |
| KONG, Y; MCINTOSH, HD; MORRIS, JJ | 1 |
| BRADLEY, E; KORSGREN, M; LESKINEN, E; PETERHOFF, V; VARNAUSKAS, E | 1 |
| BEAULNES, A; LAVALLEE, M | 1 |
| BHARGAVA, AN; CHANDRA, K; DHANDA, PC | 1 |
| HEMMER, ML; WINBURY, MM | 1 |
| CARBONELL, LM; SANABRIA, A; SOTO, R | 1 |
| AZAN, L; CALVINO, JM; CASTELLANOS, A; PEREZ-SANZ, T | 1 |
| BINDER, MJ; ROSOVE, L | 1 |
| DE JONGH, DK; KNOPPERS, AT; VAN PROOSDIJ-HARTZEMA, EG | 1 |
| FEIGIN, EV; WEISMAN, SA | 1 |
| Napolitano, C; Priori, SG | 1 |
| Morita, H; Morita, ST; Wu, J; Zipes, DP | 1 |
| Balasubramaniam, R; Colledge, WH; Goddard, CA; Grace, AA; Huang, CL; Stokoe, KS | 1 |
| Amirault, JC; Babuty, D; Chevalier, P; Clur, SA; Denjoy, I; Haissaguerre, M; Jesel, L; Le Marec, H; Lupoglazoff, JM; Mabo, P; Mansourati, J; Meregalli, PG; Probst, V; Sacher, F; Schott, JJ; Veltmann, C; Victor, J; Villain, E; Wilde, AA; Wolpert, C | 1 |
| Aihara, N; Kamakura, S; Kurita, T; Noda, T; Ohe, T; Ohgo, T; Okamura, H; Satomi, K; Shimizu, W; Suyama, K | 1 |
| Shvilkin, A | 1 |
| Antzelevitch, C; Belhassen, B; Márquez, MF; Viskin, S | 1 |
| Goddard, CA; Grace, AA; Huang, CL; Jones, VJ; Li, LM; Sabir, IN | 1 |
9 review(s) available for quinidine and Brugada Syndrome
| Article | Year |
|---|---|
Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Genetic Association Studies; Humans; Long QT Syndrome; Quinidine; Tachycardia, Ventricular | 2019 |
The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Humans; Quinidine; Ventricular Fibrillation | 2018 |
Quinidine-A legacy within the modern era of antiarrhythmic therapy.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Humans; Quinidine; Ventricular Fibrillation | 2019 |
Pathogenesis and management of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Electrophysiological Phenomena; Humans; Quinidine; Risk Assessment; Risk Factors | 2016 |
Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? Alternatives to Implantable Cardiac Defibrillator Therapy for Brugada Syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Catheter Ablation; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Humans; Patient Selection; Phenotype; Quinidine; Risk Assessment | 2016 |
Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Patient Selection; Phenotype; Quinidine | 2016 |
Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Quinidine; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
HEMODYNAMIC EFFECTS OF SUPRAVENTRICULAR ARRHYTHMIAS.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Catecholamines; Cats; Heart Conduction System; Hemodynamics; Metabolism; Mitral Valve Stenosis; Quinidine; Tachycardia | 1964 |
Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Humans; Muscle Proteins; Mutation; NAV1.5 Voltage-Gated Sodium Channel; Quinidine; Sodium Channels | 2006 |
3 trial(s) available for quinidine and Brugada Syndrome
| Article | Year |
|---|---|
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Cross-Over Studies; Defibrillators, Implantable; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Risk Factors; Time Factors; Ventricular Fibrillation | 2017 |
Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; Clinical Trials as Topic; Electrocardiography; Female; Humans; Longitudinal Studies; Male; Middle Aged; Quinidine; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Ventricular Fibrillation; Young Adult | 2009 |
Effects of quinidine on the action potential duration restitution property in the right ventricular outflow tract in patients with brugada syndrome.
Topics: Action Potentials; Adult; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; Female; Humans; Male; Middle Aged; Quinidine; Time Factors; Ventricular Function, Right | 2011 |
83 other study(ies) available for quinidine and Brugada Syndrome
| Article | Year |
|---|---|
Fever-Related Ventricular Fibrillation - Potential Adverse Effect of SARS-CoV-2 Vaccination in Patients With Brugada Syndrome.
Topics: Acetaminophen; Adult; Anti-Arrhythmia Agents; Antipyretics; Arrhythmias, Cardiac; Brugada Syndrome; COVID-19; COVID-19 Vaccines; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Fever; Humans; Isoproterenol; Male; Quinidine; SARS-CoV-2; Treatment Outcome; Vaccination; Ventricular Fibrillation | 2022 |
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Topics: Action Potentials; Arrhythmias, Cardiac; Bisoprolol; Brugada Syndrome; Calcium Channels, L-Type; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Quinidine | 2022 |
[Brugada syndrome with complete right bundle branch block successfully treated with low dose quinidine: a case report].
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Electrocardiography; Humans; Quinidine; Ventricular Fibrillation | 2020 |
SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
Topics: Amino Acid Sequence; Brugada Syndrome; HEK293 Cells; Heterozygote; Humans; Loss of Function Mutation; NAV1.5 Voltage-Gated Sodium Channel; Point Mutation; Quinidine | 2021 |
Type 1 Brugada-Electrocardiogram: A Rare Presentation in a 57-Year-Old Woman with Paroxysmal Atrial Fibrillation Treated with a Therapeutic Dose of Propafenone.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Brugada Syndrome; Clinical Decision-Making; Drug Substitution; Echocardiography; Electric Countershock; Female; Humans; Middle Aged; Propafenone; Quinidine; Treatment Outcome | 2021 |
Antitachycardia Pacing Effectiveness for Monomorphic Ventricular Tachycardia in Brugada Syndrome After Quinidine Administration.
Topics: Adult; Brugada Syndrome; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Electrocardiography; Humans; Male; Middle Aged; Quinidine; Tachycardia, Ventricular; Voltage-Gated Sodium Channel Blockers; Young Adult | 2018 |
Assessing the clinical efficacy of quinidine in Brugada syndrome: "Mission: Impossible"?
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Humans; Quinidine; Treatment Outcome; Ventricular Fibrillation | 2017 |
Photoallergic contact dermatitis caused by quinidine sulfate in a caregiver.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Caregivers; Dermatitis, Photoallergic; Humans; Male; Quinidine | 2017 |
Radiofrequency Ablation of Asymptomatic Brugada Syndrome: Don't Go Burning My Heart.
Topics: Anti-Arrhythmia Agents; Asymptomatic Diseases; Brugada Syndrome; Catheter Ablation; Clinical Decision-Making; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Humans; Patient Selection; Quinidine; Risk Factors; Treatment Outcome; Ventricular Fibrillation | 2018 |
Arrhythmic Events in Brugada Syndrome: A Nationwide Israeli Survey of the Clinical Characteristics, Treatment; and Long-Term Follow-up (ISRABRU-VF).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cohort Studies; Comorbidity; Defibrillators, Implantable; Electrocardiography; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Quinidine; Young Adult | 2018 |
Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Brugada Syndrome; Child; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Practice Guidelines as Topic; Quinidine; Retrospective Studies; Young Adult | 2019 |
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.
Topics: Ablation Techniques; Adolescent; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Child; Defibrillators, Implantable; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Arrest; Humans; Male; Medical History Taking; Quinidine; Risk Assessment; Risk Factors; Secondary Prevention; Syncope; Young Adult | 2019 |
Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Disease Models, Animal; Dogs; Drugs, Chinese Herbal; Myocytes, Cardiac; Patch-Clamp Techniques; Quinidine | 2013 |
Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Cross-Sectional Studies; Drug Utilization; Female; Global Health; Health Services Accessibility; Humans; Male; Needs Assessment; Quinidine; Risk Assessment; Surveys and Questionnaires; Survival Analysis; Ventricular Fibrillation | 2013 |
Quinidine for the management of electrical storm in an old patient with Brugada syndrome and syncope.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Death, Sudden, Cardiac; Electrocardiography; Humans; Male; Middle Aged; Quinidine; Syncope; Ventricular Fibrillation | 2013 |
Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
Topics: Adult; Anti-Arrhythmia Agents; Asymptomatic Diseases; Brugada Syndrome; Defibrillators, Implantable; Electric Countershock; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2014 |
Very prolonged episode of self-terminating ventricular fibrillation in a patient with Brugada syndrome.
Topics: Administration, Oral; Adult; Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electrocardiography; Follow-Up Studies; Humans; Male; Quinidine; Signal Processing, Computer-Assisted; Tachycardia, Ventricular; Unconsciousness; Ventricular Fibrillation | 2013 |
Side effects could certainly be decreased with lower dose of quinidine in asymptomatic Brugada patients, but what about efficacy? Author reply.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Female; Humans; Male; Quinidine; Ventricular Fibrillation | 2014 |
Adverse effects of long-term therapeutic doses of quinidine in asymptomatic Brugada patients: should low doses be used first?
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Female; Humans; Male; Quinidine; Ventricular Fibrillation | 2014 |
Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prevalence; Prognosis; Quinidine | 2014 |
Long-term pharmacological therapy of Brugada syndrome: is J-wave attenuation a marker of drug efficacy?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cilostazol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Phosphodiesterase 3 Inhibitors; Quinidine; Tetrazoles; Time Factors | 2014 |
Ventricular fibrillation storm in a child.
Topics: 2-Propanol; Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Brugada Syndrome; Death, Sudden, Cardiac; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Humans; Male; Predictive Value of Tests; Quinidine; Syncope; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2014 |
Lateral "Coved" ST-Segment Elevation: Exceptional but Malignant Electrocardiographic Sign in a Patient with Brugada Syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Defibrillators, Implantable; Electrocardiography, Ambulatory; Humans; Male; Quinidine; Syncope; Treatment Outcome; Ventricular Fibrillation | 2017 |
Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.
Topics: Adjuvants, Pharmaceutic; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Quinidine; Spain; Ventricular Fibrillation | 2016 |
Low-Dose Quinidine Effectively Reduced Shocks in Brugada Syndrome Patients with an Implantable Cardioverter Defibrillator: A Chinese Case Series Report.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Circadian Rhythm; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Male; Middle Aged; Quality of Life; Quinidine | 2017 |
On Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Diagnosis, Differential; Electric Countershock; Electrocardiography; Heart Rate; Humans; Prognosis; Quinidine | 2008 |
Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electrophysiologic Techniques, Cardiac; Humans; Quinidine; Registries | 2009 |
One small step.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Clinical Trials as Topic; Electrocardiography; Humans; Longitudinal Studies; Quinidine; Treatment Outcome; Ventricular Fibrillation | 2009 |
Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Dose-Response Relationship, Drug; Electrocardiography; Humans; Male; Metaproterenol; Quinidine; Treatment Outcome; Ventricular Fibrillation | 2009 |
Quinidine therapy in children affected by Brugada syndrome: are we far from a safe alternative?
Topics: Adrenergic alpha-Antagonists; Brugada Syndrome; Child; Child, Preschool; Defibrillators, Implantable; Humans; Quinidine | 2009 |
High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Disopyramide; Electrocardiography; Humans; Male; Middle Aged; Quinidine; Ventricular Fibrillation | 2010 |
A case of Brugada syndrome presenting with incessant polymorphic ventricular tachycardia.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Defibrillators, Implantable; Electrocardiography; Humans; Male; Quinidine; Syncope; Tachycardia, Ventricular; Time Factors | 2010 |
Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.
Topics: Adrenergic Agonists; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Drug Therapy, Combination; Humans; Male; Metaproterenol; Muscle Relaxants, Central; Quinidine; Quinine; Treatment Outcome | 2010 |
To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Drug Industry; Humans; Quinidine | 2010 |
To the editor--Market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Drug Industry; Humans; Product Recalls and Withdrawals; Quinidine; United States | 2010 |
To the editor: response---Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
Topics: Anti-Arrhythmia Agents; Brugada Syndrome; Empiricism; Humans; Quinidine | 2010 |
A phenotypic combination of idiopathic VF and Brugada syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Ajmaline; Anti-Arrhythmia Agents; Atrial Fibrillation; Brugada Syndrome; Bundle-Branch Block; Catheter Ablation; Defibrillators, Implantable; Electrocardiography; Humans; Male; Prosthesis Implantation; Quinidine; Treatment Outcome; Ventricular Fibrillation; Ventricular Premature Complexes | 2010 |
Atrial arrhythmogenic properties in wild-type and Scn5a+/- murine hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Function; Brugada Syndrome; Cardiac Pacing, Artificial; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Atria; Heart Ventricles; Mice; Mice, 129 Strain; Mice, Transgenic; NAV1.5 Voltage-Gated Sodium Channel; Perfusion; Quinidine; Sodium Channels; Time Factors; Ventricular Function | 2010 |
Refractory dispersion promotes conduction disturbance and arrhythmias in a Scn5a (+/-) mouse model.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Electric Stimulation; Flecainide; Heart; Heart Ventricles; Ion Channel Gating; Mice; NAV1.5 Voltage-Gated Sodium Channel; Quinidine; Refractory Period, Electrophysiological; Sodium Channels | 2011 |
Isoprenaline and quinidine to calm Brugada VF storm.
Topics: Adrenergic beta-Agonists; Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Humans; Isoproterenol; Male; Quinidine; Ventricular Fibrillation | 2012 |
Is quinidine the ideal drug for brugada syndrome?
Topics: Brugada Syndrome; Defibrillators, Implantable; Electrocardiography; Female; Heart Rate; Humans; Male; Quinidine | 2012 |
[Comparative tests of novocain, quinidine and strophanthin with respect to excitation and fibrillation of the frog heart].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart; Heart Conduction System; Humans; Procaine; Quinidine; Strophanthins | 1951 |
Sinoauricular nodal depression and atrioventricular nodal rhythm due to quinidine.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Depression; Heart; Heart Conduction System; Humans; Quinidine | 1953 |
The use of quinidine in fibrillation and defibrillation of the canine heart.
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dogs; Electric Countershock; Heart Conduction System; Humans; Quinidine; Ventricular Fibrillation | 1953 |
Antiarrhythmics. V. Tridiurecaine, a new local anaesthetic in experimentally induced atrial flutter, atrial fibrillation and ventricular arrhythmia.
Topics: Anesthetics, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Quinidine | 1956 |
Ventricular tachycardia and fibrillation following quinidine.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Quinidine; Tachycardia; Tachycardia, Ventricular; Ventricular Fibrillation | 1956 |
[Clinical observations on the use of a combination of reserpine, hydroquinidine and adenosine in the treatment of cardiac arrhythmia, and coronary disease].
Topics: Adenosine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Coronary Disease; Heart Conduction System; Humans; Quinidine; Reserpine | 1956 |
[New aspects in the therapy of cardiac rhythm disorders].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Digitalis; Digitalis Glycosides; Heart Conduction System; Niacin; Nicotinic Acids; Quinidine | 1957 |
[A new combined quinidine preparation for therapy of cardiac arrhythmia].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Plant Extracts; Procainamide; Quinidine | 1957 |
[Grave ventricular arrhythmias during quinidine and digitalis therapy of chronic auricular fibrillation].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Digitalis; Digitalis Glycosides; Heart Conduction System; Humans; Quinidine | 1958 |
Clinical use of quinidine in atrial flutter and fibrillation.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Quinidine | 1959 |
[Study of blood quinidine during the treatment of auricular flutter and fibrillation].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Quinidine | 1961 |
[Treatment of auricular flutter and fibrillation].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Digitalis; Digitalis Glycosides; Heart Conduction System; Humans; Quinidine | 1960 |
[Change in the fibrillation threshold of auricular and ventricular musculature of isolated mammalian heart after cooling and after administration of various pharmacological agents].
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart; Heart Conduction System; Humans; Hypothermia; Hypothermia, Induced; Papaverine; Procaine; Quinidine; Ventricular Fibrillation | 1960 |
[Quinidine in auriular fibrillation].
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Quinidine | 1959 |
Sex hormone studies. The effects on the cellular membrane potentials and contractility of isolated rat atrium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Estradiol; Gonadal Steroid Hormones; Heart Atria; Heart Conduction System; Membrane Potentials; Muscle Contraction; Myocardium; Progesterone; Quinidine; Rats; Sodium; Testosterone | 1963 |
Studies on prevention and abolition of fibrillation of the cat's heart by drugs.
Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Cats; Chlorpromazine; Epinephrine; Felis; Heart Conduction System; Hydroxyzine; Meclizine; Niacinamide; Perphenazine; Prednisolone; Quinidine; Reserpine; Succinates | 1963 |
[Artrial fibrillation and flutter. Pathophysiology and therapy].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Quinidine | 1963 |
A comparison of tests for antifibrillatory action.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Complexes, Premature; Cardiac Conduction System Disease; Heart Atria; Heart Conduction System; Procainamide; Procaine; Quinidine; Rabbits | 1961 |
Effects of antiarrhythmic drugs on external fibrillation and defibrillation thresholds.
Topics: Anti-Allergic Agents; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Histamine H1 Antagonists; Humans; Procainamide; Quinidine; Strophanthins; Ventricular Fibrillation | 1963 |
THIORIDAZINE HYDROCHLORIDE (MELLARIL): ITS EFFECT ON THE ELECTROCARDIOGRAM AND A REPORT OF TWO FATALITIES WITH ELECTROCARDIOGRAPHIC ABNORMALITIES.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Electrocardiography; Heart Block; Heart Conduction System; Humans; Pathology; Quinidine; Shock; Shock, Septic; Tachycardia; Thioridazine; Toxicology | 1963 |
QUINIDINE IN ATRIAL ARRHYTHMIAS.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Quinidine | 1963 |
DIRECT CURRENT EXTERNAL COUNTERSHOCK IN TREATMENT OF CARDIAC ARRYTHMIAS.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Electric Countershock; Electric Stimulation Therapy; Electrocardiography; Geriatrics; Heart Conduction System; Quinidine; Tachycardia | 1964 |
QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Chronic Disease; Digitalis; Digitalis Glycosides; Drug Therapy; Electrocardiography; Heart Conduction System; Quinidine; Syncope; Toxicology; Ventricular Fibrillation | 1964 |
TREATMENT OF REFRACTORY VENTRICULAR TACHYCARDIA AND FIBRILLATION BY THE ADMINISTRATION OF POTASSIUM AND QUINIDINE, REPORT OF A CASE.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Electrocardiography; Heart Conduction System; Humans; Potassium; Quinidine; Tachycardia; Tachycardia, Ventricular; Toxicology; Ventricular Fibrillation | 1964 |
[TREATMENT OF AURICULAR FLUTTER AND FIBRILLATION BY ELECTRIC SHOCK].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brugada Syndrome; Cardiac Conduction System Disease; Electric Countershock; Geriatrics; Heart Conduction System; Humans; Quinidine | 1964 |
CONVERSION OF ATRIAL ARRHYTHMIAS WITH DC SHOCK: PRIMARY RESULTS AND A FOLLOW-UP INVESTIGATION.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Blood Circulation; Blood Pressure; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Output; Coronary Disease; Electric Countershock; Electrocardiography; Follow-Up Studies; Heart Block; Heart Conduction System; Heart Failure; Heart Rate; Heart Valves; Hemodynamics; Humans; Mitral Valve Insufficiency; Mitral Valve Stenosis; Prognosis; Pulmonary Circulation; Pulmonary Emphysema; Quinidine; Statistics as Topic; Tachycardia | 1965 |
DIFFERENTIAL EFFECTS OF SOME PHENOTHIAZINE DERIVATIVES AGAINST CALCIUM-INDUCED VENTRICULAR ARRHYTHMIAS IN THE ISOLATED RABBIT HEART.
Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Brugada Syndrome; Calcium; Calcium Chloride; Cardiac Conduction System Disease; Chlorpromazine; Heart Conduction System; Parasympatholytics; Pharmacology; Phenothiazines; Prochlorperazine; Promethazine; Quinidine; Rabbits; Research; Toxicology; Ventricular Fibrillation | 1964 |
EFFECT OF DIGITALIS AND QUINIDINE IN A PATIENT WITH SHORT P-R INTERVAL.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Digitalis; Digitalis Glycosides; Electrocardiography; Heart Conduction System; Humans; Pulmonary Heart Disease; Quinidine; Wolff-Parkinson-White Syndrome | 1965 |
Action of quinidine, procaine amide and other compounds on experimental atrial and ventricular arrhythmias in the dog.
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Dogs; Heart Conduction System; Procainamide; Quinidine | 1955 |
Action of procainamide, quinidine and chloroquine upon the conduction system of the dog's heart (histochemical study).
Topics: Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Chloroquine; Dogs; Heart; Heart Conduction System; Procainamide; Quinidine | 1959 |
The effects of molar sodium lactate on the widened QRS complexes occasionally seen after quinidine therapy of artial fibrillation.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Electrocardiography; Heart Conduction System; Lactates; Molar; Quinidine; Sodium Lactate | 1961 |
Paroxysmal ventricular tachycardia and fibrillation due to quinidine.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Tachycardia, Ventricular | 1952 |
Studies on the action of synephrine, neosynephrine, and quinidine on cardiac fibrillation.
Topics: Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Epinephrine; Heart Conduction System; Humans; Phenylephrine; Quinidine; Synephrine; Ventricular Fibrillation | 1952 |
Dicumarol and quinidine in the ambulatory treatment of chronic auricular fibrillation.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Cardiac Conduction System Disease; Dicumarol; Digitalis Glycosides; Embolism; Heart Conduction System; Quinidine; Rheumatic Heart Disease | 1950 |
Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Disease Models, Animal; Dogs; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Heart Ventricles; Male; Pinacidil; Quinidine; Ventricular Fibrillation; Ventricular Function, Right | 2007 |
Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Disease Models, Animal; Electric Stimulation; Electrophysiology; Female; Flecainide; Gene Expression Regulation; Heart; Male; Mice; Mice, Inbred Strains; NAV1.5 Voltage-Gated Sodium Channel; Quinidine; Sodium Channels | 2007 |
Clinical aspects and prognosis of Brugada syndrome in children.
Topics: Adolescent; Anti-Arrhythmia Agents; Brugada Syndrome; Child; Child, Preschool; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Female; Follow-Up Studies; Genes, Dominant; Humans; Infant; Male; Muscle Proteins; NAV1.5 Voltage-Gated Sodium Channel; Prognosis; Quinidine; Sodium Channel Blockers; Sodium Channels; Syncope; Tachycardia, Supraventricular | 2007 |
Brugada syndrome in children: don't ask, don't tell?
Topics: Adolescent; Adult; Age Factors; Anti-Arrhythmia Agents; Brugada Syndrome; Child; Defibrillators, Implantable; Directive Counseling; Electrocardiography; Female; Genes, Dominant; Humans; Male; Middle Aged; Quinidine; Sex Factors; Ventricular Fibrillation | 2007 |
Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation.
Topics: Acute Disease; Adult; Aged; Brugada Syndrome; Chronic Disease; Death, Sudden, Cardiac; Female; Humans; Isoproterenol; Japan; Male; Middle Aged; Prospective Studies; Quinidine; Ventricular Fibrillation | 2007 |
Treatment of ventricular fibrillation storm in Brugada syndrome: weathering the storm but staying in hot water?
Topics: Brugada Syndrome; Death, Sudden, Cardiac; Humans; Isoproterenol; Quinidine; Ventricular Fibrillation | 2007 |
Quinidine: a valuable medication joins the list of 'endangered species'.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Brugada Syndrome; Defibrillators, Implantable; Drug and Narcotic Control; Electrocardiography; Humans; Quinidine; Ventricular Fibrillation | 2007 |
Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Brugada Syndrome; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Endocardium; Flecainide; Heart Rate; Long QT Syndrome; Mice; Mice, Transgenic; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Perfusion; Pericardium; Quinidine; Sodium Channels; Time Factors | 2008 |